109 related articles for article (PubMed ID: 14518302)
1. [COX-2 associated loss of apoptosis activity in intestinal neoplams in Apc gene knock-out mice].
Schmehl K; Jacobasch G; Buhr HJ
Langenbecks Arch Chir Suppl Kongressbd; 1998; 115(Suppl I):479-83. PubMed ID: 14518302
[TBL] [Abstract][Full Text] [Related]
2. Age-associated changes in the expression pattern of cyclooxygenase-2 and related apoptotic markers in the cancer susceptible region of rat prostate.
Badawi AF; Liu Y; Eldeen MB; Morrow W; Razak ZR; Maradeo M; Badr MZ
Carcinogenesis; 2004 Sep; 25(9):1681-8. PubMed ID: 15117812
[TBL] [Abstract][Full Text] [Related]
3. Molecular analysis of sulindac-resistant adenomas in familial adenomatous polyposis.
Keller JJ; Offerhaus GJ; Drillenburg P; Caspers E; Musler A; Ristimäki A; Giardiello FM
Clin Cancer Res; 2001 Dec; 7(12):4000-7. PubMed ID: 11751493
[TBL] [Abstract][Full Text] [Related]
4. Cyclooxygenase-2 overexpression and tumor formation are blocked by sulindac in a murine model of familial adenomatous polyposis.
Boolbol SK; Dannenberg AJ; Chadburn A; Martucci C; Guo XJ; Ramonetti JT; Abreu-Goris M; Newmark HL; Lipkin ML; DeCosse JJ; Bertagnolli MM
Cancer Res; 1996 Jun; 56(11):2556-60. PubMed ID: 8653697
[TBL] [Abstract][Full Text] [Related]
5. Effects of prostaglandin E(2) on proliferation and apoptosis of epithelial ovarian cancer cells.
Munkarah AR; Morris R; Baumann P; Deppe G; Malone J; Diamond MP; Saed GM
J Soc Gynecol Investig; 2002; 9(3):168-73. PubMed ID: 12009392
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical characteristics of duodenal adenomas in familial adenomatous polyposis with special reference to cell kinetics.
Esaki M; Matsumoto T; Yao S; Nakamura S; Hirahashi M; Yao T; Iida M
Hum Pathol; 2005 Jan; 36(1):66-73. PubMed ID: 15712184
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of intestinal polyposis with reduced angiogenesis in ApcMin/+ mice due to decreases in c-Myc expression.
Yekkala K; Baudino TA
Mol Cancer Res; 2007 Dec; 5(12):1296-303. PubMed ID: 18171987
[TBL] [Abstract][Full Text] [Related]
8. Acceleration of intestinal polyposis through prostaglandin receptor EP2 in Apc(Delta 716) knockout mice.
Sonoshita M; Takaku K; Sasaki N; Sugimoto Y; Ushikubi F; Narumiya S; Oshima M; Taketo MM
Nat Med; 2001 Sep; 7(9):1048-51. PubMed ID: 11533709
[TBL] [Abstract][Full Text] [Related]
9. Increased cyclooxygenase-2 expression in duodenal compared with colonic tissues in familial adenomatous polyposis and relationship to the -765G -> C COX-2 polymorphism.
Brosens LA; Iacobuzio-Donahue CA; Keller JJ; Hustinx SR; Carvalho R; Morsink FH; Hylind LM; Offerhaus GJ; Giardiello FM; Goggins M
Clin Cancer Res; 2005 Jun; 11(11):4090-6. PubMed ID: 15930344
[TBL] [Abstract][Full Text] [Related]
10. Microadenomatous lesions involving loss of Apc heterozygosity in the colon of adult Apc(Min/+) mice.
Yamada Y; Hata K; Hirose Y; Hara A; Sugie S; Kuno T; Yoshimi N; Tanaka T; Mori H
Cancer Res; 2002 Nov; 62(22):6367-70. PubMed ID: 12438216
[TBL] [Abstract][Full Text] [Related]
11. Damage-induced apoptosis in intestinal epithelia from bcl-2-null and bax-null mice: investigations of the mechanistic determinants of epithelial apoptosis in vivo.
Pritchard DM; Potten CS; Korsmeyer SJ; Roberts S; Hickman JA
Oncogene; 1999 Dec; 18(51):7287-93. PubMed ID: 10602483
[TBL] [Abstract][Full Text] [Related]
12. Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2).
Oshima M; Dinchuk JE; Kargman SL; Oshima H; Hancock B; Kwong E; Trzaskos JM; Evans JF; Taketo MM
Cell; 1996 Nov; 87(5):803-9. PubMed ID: 8945508
[TBL] [Abstract][Full Text] [Related]
13. Expression of cyclooxygenase-2, Bcl-2 and Ki-67 in pleomorphic adenoma with special reference to tumor proliferation and apoptosis.
Aoki T; Tsukinoki K; Karakida K; Ota Y; Otsuru M; Kaneko A
Oral Oncol; 2004 Oct; 40(9):954-9. PubMed ID: 15380175
[TBL] [Abstract][Full Text] [Related]
14. [The transgenic mouse model of familial polyposis coli].
Fehmann HC; Eissele R
Z Gastroenterol; 1997 Nov; 35(11):1035-7. PubMed ID: 9490555
[No Abstract] [Full Text] [Related]
15. Cyclooxygenase-2 expression in FAP patients carrying germ line MYH mutations.
Frattini M; Carnevali I; Signoroni S; Balestra D; Moiraghi ML; Radice P; Varesco L; Gismondi V; Ballardini G; Sala P; Pierotti MA; Pilotti S; Bertario L
Cancer Epidemiol Biomarkers Prev; 2005 Aug; 14(8):2049-52. PubMed ID: 16103460
[TBL] [Abstract][Full Text] [Related]
16. Cyclooxygenase 2 is up-regulated and localized to macrophages in the intestine of Min mice.
Hull MA; Booth JK; Tisbury A; Scott N; Bonifer C; Markham AF; Coletta PL
Br J Cancer; 1999 Mar; 79(9-10):1399-405. PubMed ID: 10188882
[TBL] [Abstract][Full Text] [Related]
17. Effects of p53 or p27 overexpression on cyclooxygenase-2 gene expression in head and neck squamous cell carcinoma cell lines.
Lee DW; Park SW; Park SY; Heo DS; Kim KH; Sung MW
Head Neck; 2004 Aug; 26(8):706-15. PubMed ID: 15287038
[TBL] [Abstract][Full Text] [Related]
18. Chronic inflammation in benign prostate hyperplasia is associated with focal upregulation of cyclooxygenase-2, Bcl-2, and cell proliferation in the glandular epithelium.
Wang W; Bergh A; Damber JE
Prostate; 2004 Sep; 61(1):60-72. PubMed ID: 15287094
[TBL] [Abstract][Full Text] [Related]
19. Alteration of gene expression in normal-appearing colon mucosa of APC(min) mice and human cancer patients.
Chen LC; Hao CY; Chiu YS; Wong P; Melnick JS; Brotman M; Moretto J; Mendes F; Smith AP; Bennington JL; Moore D; Lee NM
Cancer Res; 2004 May; 64(10):3694-700. PubMed ID: 15150130
[TBL] [Abstract][Full Text] [Related]
20. Loss of TRAIL-R does not affect thymic or intestinal tumor development in p53 and adenomatous polyposis coli mutant mice.
Yue HH; Diehl GE; Winoto A
Cell Death Differ; 2005 Jan; 12(1):94-7. PubMed ID: 15514675
[No Abstract] [Full Text] [Related]
[Next] [New Search]
